ScholarX: Browsing ScholarWorks

Browsing by Yoh, KiyotakaAuthor

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

전체 가 나 다 라 마 바 사 아 자 차 카 타 파 하

Sort by: In order: Results/Page Authors/Record:

Showing results 1 to 6 of 6

SCIESCOPUS

A phase 1b study of cofetuzumab pelidotin monotherapy in patients with PTK7-expressing recurrent non-small cell lung cancer open access

Cho, Byoung Chul; Johnson, Melissa; Bar, Jair; Schaefer, Eric; Yoh, Kiyotaka; Zer, Alona; Moskovitz, Mor; Lee, Se-Hoon; Moreno, Victor; de Miguel, Maria, et al.

ArticleIssue Date2025CitationLung Cancer, v.202PublisherElsevier Ireland Ltd

SCIESCOPUS

Anti-cytotoxic T-lymphocyte-associated antigen-4 monoclonal antibody quavonlimab in combination with pembrolizumab: Safety and efficacy from a phase I study in previously treated extensive-stage small cell lung cancer

Cho, Byoung Chul; Yoh, Kiyotaka; Perets, Ruth; Nagrial, Adnan; Spigel, David R.; Gutierrez, Martin; Kim, Dong-Wan; Kotasek, Dusan; Rasco, Drew; Niu, Jiaxin, et al.

ArticleIssue Date2021CitationLUNG CANCER, v.159, pp 162 - 170PublisherELSEVIER IRELAND LTD

SCIESCOPUS

Datopotamab Deruxtecan in Advanced or Metastatic Non–Small Cell Lung Cancer With Actionable Genomic Alterations Results From the Phase II TROPION-Lung05 Study

Sands, Jacob; Ahn, Myung-Ju; Lisberg, Aaron; Cho, Byoung Chul; Blumenschein, George; Shum, Elaine; Tostivint, Elvire Pons; Goto, Yasushi; Yoh, Kiyotaka; Heist, Rebecca, et al.

ArticleIssue Date2025CitationJournal of Clinical Oncology, v.43, no.10PublisherLippincott Williams and Wilkins

SCIESCOPUS

HERTHENA-Lung01, a Phase II Trial of Patritumab Deruxtecan (HER3-DXd) in Epidermal Growth Factor Receptor–Mutated Non–Small-Cell Lung Cancer After Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy and Platinum-Based Chemotherapy open access

Yu, Helena A.; Goto, Yasushi; Hayashi, Hidetoshi; Felip, Enriqueta; Chih-Hsin Yang, James; Reck, Martin; Yoh, Kiyotaka; Lee, Se-Hoon; Paz-Ares, Luis; Besse, Benjamin, et al.

ArticleIssue Date2023CitationJournal of Clinical Oncology, v.41, no.35, pp 5363 - 5375PublisherLippincott Williams and Wilkins

SCIESCOPUS

Intracranial efficacy of datopotamab deruxtecan (Dato-DXd) in patients (pts) with previously treated advanced/metastatic non-small cell lung cancer (a/m NSCLC) with actionable genomic alterations (AGA): Results from TROPION-Lung05

Lisberg, Aaron; Ahn, Myung-Ju; Kitazono, Satoru; Cho, Byoung Chul; Blumenschein, George R.; Shum, Elaine; Pons-Tostivint, Elvire; Goto, Yasushi; Yoh, Kiyotaka; Paz-Ares, Luis G., et al.

ArticleIssue Date2024CitationJOURNAL OF CLINICAL ONCOLOGY, v.42, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS

SCIESCOPUS

TROPION-Lung05: Datopotamab deruxtecan (Dato-DXd) in previously treated non-small cell lung cancer (NSCLC) with actionable genomic alterations (AGAs)

Atmaca, Akin; Paz-Ares, Luis; Ahn, Myung-Ju; Lisberg, Aaron; Kitazono, Satoru; Cho, Byoung Chul; Blumenschein, George, Jr.; Shum, Elaine; Tostivint, Elvire Pons; Goto, Yasushi, et al.

ArticleIssue Date2024CitationONCOLOGY RESEARCH AND TREATMENT, v.47, pp 127 - 127PublisherKARGER

STATISTICS: Total View:; Daily View:

RSS_1.0 RSS_2.0 ATOM_1.0

(03063) 25-2, SUNGKYUNKWAN-RO, JONGNO-GU, SEOUL, KOREA samsunglib@skku.edu

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Browsing by Yoh, KiyotakaAuthor

BROWSE